Overviews of Clinical Microbial Infection

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".

Deadline for manuscript submissions: 30 July 2024 | Viewed by 6133

Special Issue Editor


E-Mail Website
Guest Editor
Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece
Interests: clinical infection; antibiotics

Special Issue Information

Dear Colleagues,

The Special Issue "Overviews of Clinical Microbial Infection" highlights clinically relevant critical infections, including drug-resistant bacterial infections, bloodstream infections, viral infections, etc.

The research presented in this issue will provide valuable insights into the epidemic and the treatment and prevention of critical infectious diseases, including healthcare-associated infections, and highlight the need for further research into this important area.

This Special Issue aims to collect high-quality manuscripts (research articles, case reports, short communication, and reviews). We look forward to receiving your important contributions.

Dr. Vassiliki Pitiriga
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • infection
  • infectious disease
  • clinical

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 1263 KiB  
Review
Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Literature Review
by Mihnea Miron, Mihaela Blaj, Anca Irina Ristescu, Gabriel Iosep, Andrei-Nicolae Avădanei, Diana-Gabriela Iosep, Radu Crișan-Dabija, Alexandra Ciocan, Mihaela Perțea, Carmen Doina Manciuc, Ștefana Luca, Cristina Grigorescu and Mihaela Cătălina Luca
Microorganisms 2024, 12(1), 213; https://doi.org/10.3390/microorganisms12010213 - 20 Jan 2024
Viewed by 5914
Abstract
Hospital-acquired pneumonia (HAP) and its subtype, ventilator-associated pneumonia (VAP), remain two significant causes of morbidity and mortality worldwide, despite the better understanding of pathophysiological mechanisms, etiology, risk factors, preventive methods (bundle of care principles) and supportive care. Prior detection of the risk factors [...] Read more.
Hospital-acquired pneumonia (HAP) and its subtype, ventilator-associated pneumonia (VAP), remain two significant causes of morbidity and mortality worldwide, despite the better understanding of pathophysiological mechanisms, etiology, risk factors, preventive methods (bundle of care principles) and supportive care. Prior detection of the risk factors combined with a clear clinical judgement based on clinical scores and dosage of different inflammatory biomarkers (procalcitonin, soluble triggering receptor expressed on myelloid cells type 1, C-reactive protein, mid-regional pro-adrenomedullin, mid-regional pro-atrial natriuretic peptide) represent the cornerstones of a well-established management plan by improving patient’s outcome. This review article provides an overview of the newly approved terminology considering nosocomial pneumonia, as well as the risk factors, biomarkers, diagnostic methods and new treatment options that can guide the management of this spectrum of infections. Full article
(This article belongs to the Special Issue Overviews of Clinical Microbial Infection)
Show Figures

Figure 1

Back to TopTop